Page last updated: 2024-08-22

poloxalene and Fasciola Infection

poloxalene has been researched along with Fasciola Infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baska, P; Bertagnolli da Rosa, L; Dezen, D; Duarte, MMMF; Henker, LC; Januszkiewicz, K; Lucca, NJ; Mendes, RE; Moresco, RN; Norbury, L; Piva, MM; Prior, KC; Schwertz, CI	1

Other Studies

1 other study(ies) available for poloxalene and Fasciola Infection

Article	Year
Immune protection conferred by recombinant MRLC (myosin regulatory light chain) antigen in TiterMax Gold® adjuvant against experimental fasciolosis in rats. Vaccine, 2017, 01-23, Volume: 35, Issue:4 Topics: Adjuvants, Immunologic; Animals; Antibodies, Helminth; Antigens, Helminth; Cytokines; Disease Models, Animal; Fascioliasis; Feces; Immunoglobulin G; Male; Myosin Light Chains; Parasite Egg Count; Parasite Load; Poloxalene; Rats, Wistar; Recombinant Proteins; Th1 Cells; Th2 Cells; Vaccines, Synthetic	2017

Article

Year

Immune protection conferred by recombinant MRLC (myosin regulatory light chain) antigen in TiterMax Gold® adjuvant against experimental fasciolosis in rats.

Vaccine, 2017, 01-23, Volume: 35, Issue:4

Topics: Adjuvants, Immunologic; Animals; Antibodies, Helminth; Antigens, Helminth; Cytokines; Disease Models, Animal; Fascioliasis; Feces; Immunoglobulin G; Male; Myosin Light Chains; Parasite Egg Count; Parasite Load; Poloxalene; Rats, Wistar; Recombinant Proteins; Th1 Cells; Th2 Cells; Vaccines, Synthetic

2017